These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 10803514)
1. Clonal variability in CD95 expression is the major determinant in Fas-medicated, but not chemotherapy-medicated apoptosis in the RPMI 8226 multiple myeloma cell line. Shain KH; Landowski TH; Buyuksal I; Cantor AB; Dalton WS Leukemia; 2000 May; 14(5):830-40. PubMed ID: 10803514 [TBL] [Abstract][Full Text] [Related]
2. Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: evidence for independent mechanisms of caspase activation. Landowski TH; Shain KH; Oshiro MM; Buyuksal I; Painter JS; Dalton WS Blood; 1999 Jul; 94(1):265-74. PubMed ID: 10381522 [TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221 [TBL] [Abstract][Full Text] [Related]
4. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis. Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532 [TBL] [Abstract][Full Text] [Related]
5. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Wesselborg S; Engels IH; Rossmann E; Los M; Schulze-Osthoff K Blood; 1999 May; 93(9):3053-63. PubMed ID: 10216102 [TBL] [Abstract][Full Text] [Related]
6. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway. Ferreira CG; Tolis C; Span SW; Peters GJ; van Lopik T; Kummer AJ; Pinedo HM; Giaccone G Clin Cancer Res; 2000 Jan; 6(1):203-12. PubMed ID: 10656451 [TBL] [Abstract][Full Text] [Related]
7. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells. Fulda S; Strauss G; Meyer E; Debatin KM Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716 [TBL] [Abstract][Full Text] [Related]
8. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis. Pohl U; Wagenknecht B; Naumann U; Weller M Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342 [TBL] [Abstract][Full Text] [Related]
9. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation. Boesen-de Cock JG; Tepper AD; de Vries E; van Blitterswijk WJ; Borst J J Biol Chem; 1999 May; 274(20):14255-61. PubMed ID: 10318846 [TBL] [Abstract][Full Text] [Related]
10. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. Raisova M; Bektas M; Wieder T; Daniel P; Eberle J; Orfanos CE; Geilen CC FEBS Lett; 2000 May; 473(1):27-32. PubMed ID: 10802053 [TBL] [Abstract][Full Text] [Related]
11. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Gajate C; Mollinedo F Blood; 2007 Jan; 109(2):711-9. PubMed ID: 17003375 [TBL] [Abstract][Full Text] [Related]
12. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model. Greil R; Egle A; Villunger A Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038 [TBL] [Abstract][Full Text] [Related]
13. Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent. Evens AM; Prachand S; Shi B; Paniaqua M; Gordon LI; Gartenhaus RB Clin Cancer Res; 2004 Feb; 10(4):1481-91. PubMed ID: 14977852 [TBL] [Abstract][Full Text] [Related]
14. The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis. Müller M; Scaffidi CA; Galle PR; Stremmel W; Krammer PH Eur Cytokine Netw; 1998 Dec; 9(4):685-6. PubMed ID: 9889415 [TBL] [Abstract][Full Text] [Related]
15. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Reis-Sobreiro M; Gajate C; Mollinedo F Oncogene; 2009 Sep; 28(36):3221-34. PubMed ID: 19561642 [TBL] [Abstract][Full Text] [Related]
16. Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line. Irisarri M; Plumas J; Bonnefoix T; Jacob MC; Roucard C; Pasquier MA; Sotto JJ; Lajmanovich A Leukemia; 2000 Dec; 14(12):2149-58. PubMed ID: 11187905 [TBL] [Abstract][Full Text] [Related]
17. TCR stimulation protects CD8+ T cells from CD95 mediated apoptosis. Karas M; Zaks TZ; Yakar S; Dudley ME; LeRoith D Hum Immunol; 2001 Jan; 62(1):32-8. PubMed ID: 11165713 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system. McGahon AJ; Costa Pereira AP; Daly L; Cotter TG Br J Haematol; 1998 Jun; 101(3):539-47. PubMed ID: 9633899 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation. Bian X; Giordano TD; Lin HJ; Solomon G; Castle VP; Opipari AW J Biol Chem; 2004 Feb; 279(6):4663-9. PubMed ID: 14617634 [TBL] [Abstract][Full Text] [Related]
20. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis. Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]